{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:36:30Z","timestamp":1761129390232,"version":"3.41.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,10,27]],"date-time":"2016-10-27T00:00:00Z","timestamp":1477526400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003751","name":"Ministerio de Sanidad, Servicios Sociales e Igualdad","doi-asserted-by":"publisher","award":["PI15\/01017"],"award-info":[{"award-number":["PI15\/01017"]}],"id":[{"id":"10.13039\/501100003751","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003751","name":"Ministerio de Sanidad, Servicios Sociales e Igualdad","doi-asserted-by":"publisher","award":["RD12\/0017\/0012"],"award-info":[{"award-number":["RD12\/0017\/0012"]}],"id":[{"id":"10.13039\/501100003751","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fundaci\u00f3n Progreso y Salud","award":["0024-RH-2013"],"award-info":[{"award-number":["0024-RH-2013"]}]},{"name":"Fundaci\u00f3n Progreso y Salud","award":["AC-0095-2013"],"award-info":[{"award-number":["AC-0095-2013"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1007\/s10096-016-2822-6","type":"journal-article","created":{"date-parts":[[2016,10,27]],"date-time":"2016-10-27T07:49:14Z","timestamp":1477554554000},"page":"487-494","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Impact of universal access to hepatitis C therapy on HIV-infected patients: implementation of the Spanish national hepatitis C strategy"],"prefix":"10.1007","volume":"36","author":[{"name":"on behalf of the HERACLES cohort study team of the Grupo de Estudio de Hepatitis Virales (HEPAVIR) of the Sociedad Andaluza de Enfermedades Infecciosas (SAEI)","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Rivero-Juarez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. F.","family":"Lopez-Cortes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Casta\u00f1o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Merino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Marquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Mancebo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Cuenca-Lopez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Jimenez-Aguilar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Lopez-Montesinos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Lopez-Cardenas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Collado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. A.","family":"Lopez-Ruz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Omar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Tellez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"X.","family":"Perez-Stachowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Hernandez-Quero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. A.","family":"Gir\u00f3n-Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Fernandez-Fuertes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Rivero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,10,27]]},"reference":[{"key":"2822_CR1","unstructured":"Recommendations for Testing, Managing, and Treating Hepatitis C of the American Association for the Study of Liver Diseases (AASLD) and the Infectious Diseases Society of America (IDSA). Available online at: http:\/\/www.hcvguidelines.org . Last accessed June 5th 2016"},{"key":"2822_CR2","unstructured":"European Association for the Study of the Liver (EASL) Recommendations on Treatment of Hepatitis C 2015. Available online at: http:\/\/www.easl.eu\/research\/our-contributions\/clinical-practice-guidelines\/detail\/recommendations-on-treatment-of-hepatitis-c-2015 . Last accessed June 5th 2016"},{"key":"2822_CR3","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1093\/cid\/cit103","volume":"56","author":"JA Mira","year":"2013","unstructured":"Mira JA, Rivero-Ju\u00e1rez A, L\u00f3pez-Cort\u00e9s LF et al (2013) Benefits from sustained virologic response to pegylated interferon plus ribavirin in HIV\/hepatitis C virus-coinfected patients with compensated cirrhosis. Clin Infect Dis 56:1646\u20131653","journal-title":"Clin Infect Dis"},{"key":"2822_CR4","unstructured":"Plan estrat\u00e9gico para el abordaje de la Hepatitis c en el Sistema Nacional de Salud. Available online at: http:\/\/www.msssi.gob.es\/ciudadanos\/enfLesiones\/enfTransmisibles\/docs\/plan_estrategico_hepatitis_C.pdf . Last accessed June 5th 2016"},{"key":"2822_CR5","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1093\/cid\/cis404","volume":"55","author":"AD Branch","year":"2012","unstructured":"Branch AD, Van Natta ML, Vachon ML et al (2012) Mortality in hepatitis C virus-infected patients with a diagnosis of AIDS in the era of combination antiretroviral therapy. Clin Infect Dis 55:137\u2013144","journal-title":"Clin Infect Dis"},{"key":"2822_CR6","doi-asserted-by":"crossref","unstructured":"Neukam K, Suarez Santamar\u00eda M, Rivero-Ju\u00e1rez A et al (2016) HIV coinfection impairs the response to DAA-based HCV therapy. The International Liver Congress, Barcelona, Spain, April 13\u201317 2016. Abstract LB-P513","DOI":"10.1016\/S0168-8278(16)00190-2"},{"key":"2822_CR7","doi-asserted-by":"crossref","first-page":"369","DOI":"10.7326\/M13-1829","volume":"160","author":"V Lo Re 3rd","year":"2014","unstructured":"Lo Re V 3rd, Kallan MJ, Tate JP et al (2014) Hepatic decompensation in antiretroviral-treated patients co-infected with HIV and hepatitis C virus compared with hepatitis C virus-monoinfected patients: a cohort study. Ann Intern Med 160:369\u2013379","journal-title":"Ann Intern Med"},{"key":"2822_CR8","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/hep.21757","volume":"46","author":"JA Pineda","year":"2007","unstructured":"Pineda JA, Garc\u00eda-Garc\u00eda JA, Aguilar-Guisado M et al (2007) Clinical progression of hepatitis C virus-related chronic liver disease in human immunodeficiency virus-infected patients undergoing highly active antiretroviral therapy. Hepatology 46:622\u2013630","journal-title":"Hepatology"},{"key":"2822_CR9","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1007\/s10096-015-2476-9","volume":"34","author":"A Rivero-Juarez","year":"2015","unstructured":"Rivero-Juarez A, Gutierrez-Valencia A, Casta\u00f1o M et al (2015) Dimension of chronic hepatitis C virus in HIV-infected patients in the interferon-free era: an overview from south Spain. Eur J Clin Microbiol Infect Dis 34:2247\u20132255","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2822_CR10","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/01.aids.0000198087.47454.e1","volume":"20","author":"N Merchante","year":"2006","unstructured":"Merchante N, Gir\u00f3n-Gonz\u00e1lez JA, Gonz\u00e1lez-Serrano M et al (2006) Survival and prognostic factors of HIV-infected patients with HCV-related end-stage liver disease. AIDS 20:49\u201357","journal-title":"AIDS"},{"key":"2822_CR11","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1093\/cid\/cit537","volume":"57","author":"J Mac\u00edas","year":"2013","unstructured":"Mac\u00edas J, M\u00e1rquez M, T\u00e9llez F et al (2013) Risk of liver decompensation among HIV\/hepatitis C virus-coinfected individuals with advanced fibrosis: implications for the timing of therapy. Clin Infect Dis 57:1401\u20131408","journal-title":"Clin Infect Dis"},{"key":"2822_CR12","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1001\/jama.2012.144878","volume":"308","author":"AJ Meer van der","year":"2012","unstructured":"van der Meer AJ, Veldt BJ, Feld JJ et al (2012) Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis. JAMA 308:2584\u20132593","journal-title":"JAMA"},{"key":"2822_CR13","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jhep.2016.02.007","volume":"65","author":"NK Martin","year":"2016","unstructured":"Martin NK, Vickerman P, Dore GJ et al (2016) Prioritization of HCV treatment in the direct-acting antiviral era: An economic evaluation. J Hepatol 65:17\u201325","journal-title":"J Hepatol"},{"key":"2822_CR14","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1002\/hep.23136","volume":"50","author":"J Mac\u00edas","year":"2009","unstructured":"Mac\u00edas J, Berenguer J, Jap\u00f3n MA et al (2009) Fast fibrosis progression between repeated liver biopsies in patients coinfected with human immunodeficiency virus\/hepatitis C virus. Hepatology 50:1056\u20131063","journal-title":"Hepatology"},{"key":"2822_CR15","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/nrgastro.2014.17","volume":"11","author":"JY Chen","year":"2014","unstructured":"Chen JY, Feeney ER, Chung RT (2014) HCV and HIV co-infection: mechanisms and management. Nat Rev Gastroenterol Hepatol 11:362\u2013371","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2822_CR16","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/infdis\/jis385","volume":"206","author":"MH Lee","year":"2012","unstructured":"Lee MH, Yang HI, Lu SN et al (2012) Chronic hepatitis C virus infection increases mortality from hepatic and extrahepatic diseases: a community-based long-term prospective study. J Infect Dis 206:469\u2013477","journal-title":"J Infect Dis"},{"key":"2822_CR17","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1097\/QAD.0b013e3282f10de9","volume":"21","author":"MS Sulkowski","year":"2007","unstructured":"Sulkowski MS, Mehta SH, Torbenson MS et al (2007) Rapid fibrosis progression among HIV\/hepatitis C virus-co-infected adults. AIDS 21:2209\u20132216","journal-title":"AIDS"},{"key":"2822_CR18","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1097\/QAD.0b013e3283319184","volume":"23","author":"MJ Silverberg","year":"2009","unstructured":"Silverberg MJ, Chao C, Leyden WA et al (2009) HIV infection and the risk of cancers with and without a known infectious cause. AIDS 23:2337\u20132345","journal-title":"AIDS"},{"key":"2822_CR19","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0140-6736(07)61050-2","volume":"370","author":"AE Grulich","year":"2007","unstructured":"Grulich AE, van Leeuwen MT, Falster MO et al (2007) Incidence of cancers in people with HIV\/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet 370:59\u201367","journal-title":"Lancet"},{"key":"2822_CR20","doi-asserted-by":"crossref","first-page":"12896","DOI":"10.3748\/wjg.v21.i45.12896","volume":"21","author":"S Fiorino","year":"2015","unstructured":"Fiorino S, Bacchi-Reggiani L, de Biase D et al (2015) Possible association between hepatitis C virus and malignancies different from hepatocellular carcinoma: A systematic review. World J Gastroenterol 21:12896\u201312953","journal-title":"World J Gastroenterol"},{"key":"2822_CR21","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1097\/QAD.0b013e32833c7b9c","volume":"24","author":"C Smith","year":"2010","unstructured":"Data Collection on Adverse Events of Anti-HIV drugs (D:A:D) Study Group, Smith C, Sabin CA et al (2010) Factors associated with specific causes of death amongst HIV-positive individuals in the D:A:D Study. AIDS 24:1537\u20131548","journal-title":"AIDS"},{"key":"2822_CR22","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/QAI.0b013e3181e9be6b","volume":"55","author":"A Mocroft","year":"2010","unstructured":"Mocroft A, Reiss P, Gasiorowski J et al (2010) Serious fatal and nonfatal non-AIDS-defining illnesses in Europe. J Acquir Immune Defic Syndr 55:262\u2013270","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2822_CR23","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/CRD.0000000000000031","volume":"23","author":"V Katsi","year":"2015","unstructured":"Katsi V, Felekos I, Skevofilax S et al (2015) Cardiovascular disease and hepatitis C virus infection: an irrelevant statement or a hot relationship? Cardiol Rev 23:11\u201317","journal-title":"Cardiol Rev"},{"key":"2822_CR24","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1157\/13076173","volume":"23","author":"JJ Gonz\u00e1lez-Garc\u00eda","year":"2005","unstructured":"Gonz\u00e1lez-Garc\u00eda JJ, Mahillo B, Hern\u00e1ndez S et al (2005) Prevalences of hepatitis virus coinfection and indications for chronic hepatitis C virus treatment and liver transplantation in Spanish HIV-infected patients. The GESIDA 29\/02 and FIPSE 12185\/01 Multicenter Study. Enferm Infecc Microbiol Clin 23:340\u2013348","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"2822_CR25","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/jvh.12353","volume":"22","author":"S Serrano-Villar","year":"2015","unstructured":"Serrano-Villar S, Sobrino-Vegas P, Monge S et al (2015) Decreasing prevalence of HCV coinfection in all risk groups for HIV infection between 2004 and 2011 in Spain. J Viral Hepat 22:496\u2013503","journal-title":"J Viral Hepat"},{"key":"2822_CR26","doi-asserted-by":"crossref","first-page":"ofw059","DOI":"10.1093\/ofid\/ofw059","volume":"3","author":"J Berenguer","year":"2016","unstructured":"Berenguer J, Rivero A, Jarr\u00edn I et al (2016) Human immunodeficiency virus\/hepatitis C virus coinfection in Spain: prevalence and patient characteristics. Open Forum Infect Dis 3:ofw059","journal-title":"Open Forum Infect Dis"},{"key":"2822_CR27","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1086\/598333","volume":"48","author":"S P\u00e9rez Cachafeiro","year":"2009","unstructured":"P\u00e9rez Cachafeiro S, Del Amo J, Iribarren JA et al (2009) Decrease in serial prevalence of coinfection with hepatitis C virus among HIV-infected patients in Spain, 1997\u20132006. Clin Infect Dis 48:1467\u20131470","journal-title":"Clin Infect Dis"},{"key":"2822_CR28","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jhep.2013.04.005","volume":"59","author":"JK Rockstroh","year":"2013","unstructured":"Rockstroh JK, Peters L, Grint D et al (2013) Does hepatitis C viremia or genotype predict the risk of mortality in individuals co-infected with HIV? J Hepatol 59:213\u2013220","journal-title":"J Hepatol"},{"key":"2822_CR29","doi-asserted-by":"crossref","first-page":"764540","DOI":"10.1155\/2014\/764540","volume":"2014","author":"S Erqou","year":"2014","unstructured":"Erqou S, Mohanty A, Murtaza Kasi P et al (2014) Predictors of mortality among United States veterans with human immunodeficiency virus and hepatitis C virus coinfection. ISRN Gastroenterol 2014:764540","journal-title":"ISRN Gastroenterol"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-016-2822-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-016-2822-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-016-2822-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T21:42:14Z","timestamp":1749678134000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-016-2822-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,27]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["2822"],"URL":"https:\/\/doi.org\/10.1007\/s10096-016-2822-6","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"type":"print","value":"0934-9723"},{"type":"electronic","value":"1435-4373"}],"subject":[],"published":{"date-parts":[[2016,10,27]]}}}